Patheon Stock Price, News & Analysis (NYSE:PTHN)

$34.98 0.00 (0.00 %)
(As of 01/23/2018 08:28 AM ET)
Previous Close$34.98
Today's Range$34.98 - $35.02
52-Week Range$23.72 - $35.13
Volume229,700 shs
Average Volume754,718 shs
Market Capitalization$5.08 billion
P/E Ratio46.64
Dividend YieldN/A

About Patheon (NYSE:PTHN)

Patheon logoPatheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company's segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products. The PDS segment provides a range of formulation, production and technical services from the early stages of a product's development to regulatory approval, as well as for new formulations of approved products for lifecycle extension. The DSS segment provides small molecule active pharmaceutical ingredient (API) and outsourced manufacturing solutions for large molecule biological API from early development through commercial scale production. It provides an integrated range of API and finished drug product services to its customers, from formulation development to clinical and commercial-scale manufacturing.

Receive PTHN News and Ratings via Email

Sign-up to receive the latest news and ratings for PTHN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals


Debt-to-Equity Ratio-7.33%
Current Ratio1.65%
Quick Ratio0.91%


Trailing P/E Ratio46.64
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.87 billion
Price / Sales2.72
Cash FlowN/A
Price / CashN/A
Book Value($2.40) per share
Price / Book-14.58


Trailing EPS$0.75
Net Income$31.70 million
Net Margins5.63%
Return on Equity-35.93%
Return on Assets4.18%


Outstanding Shares145,140,000

Patheon (NYSE:PTHN) Frequently Asked Questions

What is Patheon's stock symbol?

Patheon trades on the New York Stock Exchange (NYSE) under the ticker symbol "PTHN."

How were Patheon's earnings last quarter?

Patheon NV (NYSE:PTHN) posted its earnings results on Thursday, June, 8th. The company reported $0.20 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.19 by $0.01. The business earned $483.40 million during the quarter, compared to the consensus estimate of $466.08 million. Patheon had a negative return on equity of 35.93% and a net margin of 5.63%. The business's revenue for the quarter was up 3.2% compared to the same quarter last year. View Patheon's Earnings History.

Where is Patheon's stock going? Where will Patheon's stock price be in 2018?

7 equities research analysts have issued 12-month price objectives for Patheon's stock. Their predictions range from $28.00 to $35.00. On average, they anticipate Patheon's share price to reach $33.60 in the next year. View Analyst Ratings for Patheon.

Who are some of Patheon's key competitors?

Who are Patheon's key executives?

Patheon's management team includes the folowing people:

  • Paul S. Levy, Chairman of the Board
  • James C. Mullen, Chief Executive Officer, Director
  • Stuart R. Grant, Chief Financial Officer, Executive Vice President
  • Gilles A. Cottier, President - Global Pharmaceutical Development Services
  • Franco Negron, President - Drug Product Services
  • Lukas Utiger, President - Drug Substance
  • Michael J. Lehmann, Executive Vice President - Global Sales and Marketing
  • Michael E. Lytton J.D., Executive Vice President - Corporate Development and Strategy
  • Rebecca Holland New, Chief Human Resources Officer and Executive Vice President - Communications and Project Management Office
  • Harry R. Gill III, Senior Vice President - Quality and Continuous Improvement

When did Patheon IPO?

(PTHN) raised $625 million in an initial public offering on Thursday, July 21st 2016. The company issued 30,500,000 shares at a price of $19.00-$22.00 per share. J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank, Credit Suisse, Evercore ISI and Wells Fargo Securities acted as the underwriters for the IPO and Baird, Piper Jaffray, Raymond James, William Blair, KeyBanc Capital Markets and Leerink Partners were co-managers.

How do I buy Patheon stock?

Shares of Patheon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Patheon's stock price today?

One share of Patheon stock can currently be purchased for approximately $34.98.

How big of a company is Patheon?

Patheon has a market capitalization of $5.08 billion and generates $1.87 billion in revenue each year. The company earns $31.70 million in net income (profit) each year or $0.75 on an earnings per share basis. Patheon employs 9,100 workers across the globe.

How can I contact Patheon?

Patheon's mailing address is Herengracht 483, Amsterdam P7, 1017BT. The company can be reached via phone at 31-20-622-3243.

MarketBeat Community Rating for Patheon (PTHN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  242
MarketBeat's community ratings are surveys of what our community members think about Patheon and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Patheon (NYSE:PTHN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
7 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $33.60$33.60$33.60$32.45
Price Target Upside: 3.81% downside3.81% downside3.81% downside7.10% downside

Patheon (NYSE:PTHN) Consensus Price Target History

Price Target History for Patheon (NYSE:PTHN)

Patheon (NYSE:PTHN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/21/2017Jefferies GroupReiterated RatingHold$35.00LowView Rating Details
6/9/2017Leerink SwannDowngradeOutperform -> Market Perform$31.00 -> $35.00LowView Rating Details
6/9/2017Raymond James FinancialDowngradeOutperform -> Mkt PerformLowView Rating Details
6/8/2017JPMorgan Chase & Co.DowngradeOverweight -> NeutralLowView Rating Details
5/15/2017Evercore ISIDowngradeOutperform$35.00LowView Rating Details
5/15/2017William BlairDowngradeOutperform -> Market PerformLowView Rating Details
5/15/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralLowView Rating Details
3/17/2017Robert W. BairdDowngradeOutperform -> Neutral$34.00 -> $28.00LowView Rating Details
8/16/2016Credit Suisse GroupInitiated CoverageNeutral$30.00N/AView Rating Details
8/15/2016Wells Fargo & CoInitiated CoverageOutperformN/AView Rating Details
8/15/2016Morgan StanleyInitiated CoverageOverweight$31.00N/AView Rating Details
8/15/2016KeyCorpInitiated CoverageOverweight$33.00N/AView Rating Details
(Data available from 1/23/2016 forward)


Patheon (NYSE:PTHN) Earnings History and Estimates Chart

Earnings by Quarter for Patheon (NYSE:PTHN)

Patheon (NYSE PTHN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/8/20174/30/2017$0.19$0.20$466.08 million$483.40 millionViewN/AView Earnings Details
3/16/20171/31/2017$0.22$0.14$463.39 million$457.40 millionViewN/AView Earnings Details
12/20/2016Q416$0.39$0.30$496.27 million$510.20 millionViewN/AView Earnings Details
9/8/2016Q3 2016$0.07ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Patheon (NYSE:PTHN) Earnings Estimates

Current Year EPS Consensus Estimate: $1.01 EPS


Dividend History for Patheon (NYSE:PTHN)

No dividend announcements for this company have been tracked by

Insider Trades

Patheon (NYSE PTHN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.14%
Institutional Ownership Percentage: 0.58%
Insider Trades by Quarter for Patheon (NYSE:PTHN)
Institutional Ownership by Quarter for Patheon (NYSE:PTHN)

Patheon (NYSE PTHN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/30/2016Paul S LevyDirectorBuy10,000$29.55$295,500.00View SEC Filing  
9/28/2016Paul S LevyDirectorBuy15,000$29.64$444,600.00View SEC Filing  
9/12/2016Paul S LevyDirectorBuy37,000$28.01$1,036,370.00View SEC Filing  
7/26/2016Jll Patheon Co-Investment FundMajor ShareholderBuy815,730$19.85$16,192,240.50View SEC Filing  
7/26/2016Pamela DaleyDirectorBuy48,800$19.85$968,680.0060,705View SEC Filing  
7/21/2016Philip EykermanDirectorBuy28,000$25.00$700,000.0028,000View SEC Filing  
(Data available from 1/1/2013 forward)


Patheon (NYSE PTHN) News Headlines

Patheon NV (PTHN) Expected to Announce Earnings of $0.43 Per SharePatheon NV (PTHN) Expected to Announce Earnings of $0.43 Per Share - January 12 at 11:28 AM
Reviewing Patheon (PTHN) and Concordia International (CXRX)Reviewing Patheon (PTHN) and Concordia International (CXRX) - December 25 at 5:30 PM
Contrasting Patheon (PTHN) & Its CompetitorsContrasting Patheon (PTHN) & Its Competitors - December 20 at 9:28 PM
Head to Head Contrast: Patheon (PTHN) and Its CompetitorsHead to Head Contrast: Patheon (PTHN) and Its Competitors - December 19 at 5:22 PM
Head to Head Comparison: Patheon (PTHN) and Its PeersHead to Head Comparison: Patheon (PTHN) and Its Peers - December 16 at 1:30 AM
Analyzing Patheon (PTHN) and Its RivalsAnalyzing Patheon (PTHN) and Its Rivals - December 13 at 1:34 PM
Patheon (PTHN) vs. Its Rivals Head to Head ContrastPatheon (PTHN) vs. Its Rivals Head to Head Contrast - November 30 at 5:34 AM
Analyzing Patheon N.V. (PTHN) and Its RivalsAnalyzing Patheon N.V. (PTHN) and Its Rivals - November 24 at 11:30 AM
Financial Review: Cambrex Corporation (CBM) versus Patheon N.V. (PTHN)Financial Review: Cambrex Corporation (CBM) versus Patheon N.V. (PTHN) - November 17 at 11:44 PM

SEC Filings

Patheon (NYSE:PTHN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Patheon (NYSE:PTHN) Income Statement, Balance Sheet and Cash Flow Statement


Patheon (NYSE PTHN) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.